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The objective was to investigate the prevalence of heart attack, angina pectoris, stroke,
hypertension, diabetes mellitus, chronic obstructive pulmonary disease, asthma and obesity
in relation to the presence and severity of obstructive sleep apnea.
Methods
The sample consisted of 1887 patients, with mean age of 48.6 years (range 16–83 years),
referred to a university hospital on suspicion of obstructive sleep apnea. The patients filled
out a questionnaire asking whether they were previously diagnosed with the comorbidities
in interest. Obstructive sleep apnea was diagnosed and categorized based on a standard
respiratory polygraphic sleep study using a type 3 portable monitor. The patients’ weight,
height and blood pressure were measured during the consultations.
Results
In total, 37.9% were categorized as not having obstructive sleep apnea (Apnea-hypopnea
index <5), 29.6% mild obstructive sleep apnea (Apnea-hypopnea index 5–14.9), 17.3%
moderate obstructive sleep apnea (Apnea-hypopnea index 15–29.9), and 15.2% severe
obstructive sleep apnea (Apnea-hypopnea index30). The prevalence of heart attack,
angina pectoris, hypertension, measured systolic blood pressure140 mmHg, measured
diastolic blood pressure90 mmHg, diabetes mellitus and obesity (body mass index30)
were higher with greater obstructive sleep apnea severity. Logistic and linear regression
analyses showed that these comorbidities were positively associated with obstructive sleep
apnea severity. This was not the case for stroke, chronic obstructive pulmonary disease and
asthma. After adjustment for sex, age, alcohol and smoking in the logistic regression analy-
ses, hypertension, measured systolic blood pressure140 mmHg, measured diastolic
blood pressure90 mmHg and obesity remained positively associated with obstructive
sleep apnea severity.
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Conclusions
A higher prevalence of heart attack, angina pectoris, hypertension, diabetes mellitus, and
obesity was seen with greater obstructive sleep apnea severity. Obesity and hypertension,
conditions easy to clinically assess, appear as the most central comorbidities with greater
obstructive sleep apnea severity.
Introduction
Obstructive sleep apnea (OSA) is a common, but often under-diagnosed disorder [1, 2]. The
prevalence of OSA in the adult Norwegian population has been estimated to be 16% for apnea-
hypopnea index (AHI)5 and 8% for AHI15 [3]. OSA affects male individuals more com-
monly than female individuals [2, 4].
OSA has been recognized as an independent risk factor for cardiovascular disease. Morbid-
ity such as stroke, myocardial infarction, unstable angina, hypertension and diabetes are asso-
ciated with the disorder [5, 6]. Greater prevalence of OSA is seen in patients with coronary
artery disease, compared to subjects without coronary artery disease [7]. It has also been
reported that men with OSA have an increased risk of developing cardiovascular disease, inde-
pendent of age, body mass index (BMI), blood pressure, and smoking [8]. The cardiovascular
risk seen in patients with severe OSA is reduced with continuous positive airway pressure
(CPAP) treatment according to Marin et al. [6].
Several studies show an association between OSA and hypertension [9–11], and OSA has
been suggested as a possible risk factor for hypertension [10]. Haentjens et al.’s meta-analysis
observed that CPAP treatment reduced blood pressure in patients with OSA, with a larger
effect in severe OSA [12], indicating a correlation between hypertension and OSA. A dose-
response relationship between OSA and blood pressure elevations independent of age, sex,
BMI and other factors has been reported [10]. However, another study did not show a statisti-
cal difference once BMI was factored out. This implicated that the development of hyperten-
sion was more closely related to obesity than to OSA [13].
There is an increasing amount of evidence suggesting a link between OSA and insulin resis-
tance and type 2 diabetes mellitus [7]. A link between OSA severity and the risk of type 2 dia-
betes mellitus, independently of obesity, is also suggested in epidemiological studies [14].
An increased incidence of stroke has been related to OSA. It has been reported that about
half of patients who had an acute stroke have sleep-related disturbances [15]. The risk for
developing stroke increases with increased severity of sleep apnea at baseline [7, 16]. Stroke
and transient ischemic attack (TIA) are also risk factors for developing obstructive apnea [7].
Chronic obstructive pulmonary disease (COPD), asthma and COPD combined with
asthma have been found to be more prevalent among OSA patients compared to matched con-
trols [17]. A recently published Norwegian general population study suggests that women with
asthma and chronic airflow limitation (assessed by spirometry with bronchodilator tests) are
at particular risk for OSA [18]. Moreover, subjects suffering from the “overlap syndrome”,
defined as co-existence of OSA and COPD, are at increased risk for exacerbations, pulmonary
hypertension and death, which might be reduced by CPAP treatment [19]. However, The
Sleep Heart Health Study reported that there was no association between mild obstructive air-
way disease and OSA [20].
According to World Health Organization’s (WHO) 10th revision of the International Clas-
sification of Diseases (ICD-10) obesity is a diagnosis, and defined as BMI greater than or equal
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to 30 [21]. OSA is clearly associated with obesity [11, 14], and Franklin et al. list it as one of the
key signs of OSA in female individuals [11]. The pathophysiology of OSA in obesity is consid-
ered to be multifactorial [14], where increased fat mass in obese individuals is a connection
[22].
Patients with OSA are often subject to somatic comorbidity, such as those mentioned
above. These conditions address different areas within medicine and there are few previous
studies that consider the vast variety of comorbidities related to OSA within a reasonable sam-
ple size. Consequently, a study evaluating the association between several of the most common
somatic comorbidities and OSA is warranted to enlighten the complexity of this patient group.
With this in mind we investigated a large group of patients with suspected OSA referred to a
major university hospital in Norway. Using a questionnaire the subjects’ somatic comorbidity
was identified and clinically evaluated during the patient visit at the hospital. The main aim of
this study was to investigate the prevalence of heart attack, angina pectoris, stroke, hyperten-
sion, diabetes mellitus, COPD, asthma and obesity in relation to the presence and severity of
OSA.
Materials and methods
The total sample consisted of 1929 patients referred to Haukeland University Hospital on sus-
picion of obstructive sleep apnea during the period of 2011 to 2014. Due to no objective regis-
trations, 42 individuals were excluded, thus the final sample included 1887 patients. The mean
age was 48.6 years (range 16–83 years) and 70.6% were men.
As described in detail previously [23], the patients underwent a standard respiratory sleep
study to diagnose whether they had OSA. This was done using a type 3 portable monitor. The
scoring rules were in accordance with the 2007 American Academy of Sleep Medicine manual.
Apneas were defined as a reduction of 90% or more of baseline nasal airflow with a duration of
at least 10 seconds. Hypopneas were defined as a nasal flow reduction of 30–90% of baseline,
lasting at least 10 seconds accompanied by an oxygen desaturation of 4%. OSA was diag-
nosed and classified according to AHI as no OSA (<5), mild (5–14.9), moderate (15–29.9) or
severe (30) OSA. The vast majority of the sleep recordings took place in the patients’ home.
The rest of the patients slept in a hospital hotel. The patient-reported time period before sleep
onset and after morning awakening were excluded from the sleep record before manual scor-
ing [23].
The patients filled out a questionnaire prior to the respiratory sleep study, S1 and S2 Survey
questions. A nurse and/or doctor revised the questionnaire during the consultation to make
sure the answers delivered were reliable. Changes were made if necessary.
The patients were asked about their current smoking habits (number of cigarettes per day).
For data analyses purposes their answers were categorized into a “no smoking” and “smoking”
variable. The latter included 1 and more cigarettes per day.
The patients’ alcohol consumption was classified as daily, 3–5 days per week, 1–2 days per
week, rarely or never. An “alcohol” variable was generated for data analyses, combining daily
consumption and 3–5 days per week. The “no alcohol” variable included 1–2 days per week,
rarely and never. This dichotomy was created to ease the analyses and differentiate between
alcohol consumption on a regular basis or rarely.
The patients were asked about whether they were previously diagnosed with heart attack
(yes/no), stroke (yes/no), diabetes mellitus (yes/no), hypertension (yes/no), angina pectoris
(yes/no), COPD (yes/no) and asthma (yes/no). Furthermore, the patients were asked whether
they currently received treatment with medication for diabetes mellitus, hypertension, angina
pectoris, COPD and asthma.
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During the consultation the patients’ sex and age were noted, and weight (kg) and height
(m) measured. Their BMI was calculated by weight in kilograms divided by squared height in
meters. Obesity was defined as BMI greater than or equal to 30.
The patients’ blood pressure was measured by a nurse and/or doctor during the consulta-
tion. Prior to the measurement the patient sat still for 10 minutes. The blood pressure was then
measured using an automatic, cuff-style, bicep monitor. Two recordings were done and the
second recording was selected. In case of strongly deviating results, the blood pressure was
measured manually.
The study was approved by the Ethics Board (The Regional Committee for Medical and
Health Related Ethics in Western Norway). Written informed consent was obtained from all
individual participants included in the study.
Statistics
The data analyses were performed using IBM SPSS Statistics version 22. Pearson chi-square
tests were used to evaluate the differences in the patients’ characteristics according to the pres-
ence and severity of OSA. Thereafter, bivariate logistic regression (crude) analyses were per-
formed with OSA severity (0 = AHI <15, 1 = AHI15) as the dependent variable. Separate
multivariate logistic regression analyses (adjusted) were then done for each characteristic
together with age and sex as co-variates. The adjusted analyses were repeated, including smok-
ing and alcohol in addition to age and sex as co-variates. Linear regressions with AHI as the
dependent variable were also performed. The comorbidity parameters of interest were further
used in crude logistic regression analyses as dependent variables, using OSA severity (mild,
moderate, severe) as co-variate. The significance level was set to 0.05.
Results
Among the patients referred on suspicion of OSA 37.9% had a normal AHI (<5), yielding a
prevalence rate of OSA of 62.1%. Out of the referred patients 29.6% had mild OSA, 17.3% had
moderate OSA, and 15.2% had severe OSA (Table 1).
Being male and alcohol consumption were associated with greater OSA severity. Smoking
was associated with lower OSA severity (Table 1).
The prevalence of heart attack, angina pectoris, hypertension, diabetes, and obesity were
significantly higher with greater OSA severity (Table 1). This was not the case for stroke,
COPD, or asthma. Measured systolic blood pressure140 mmHg and diastolic blood pressure
90 mmHg also showed a higher prevalence with greater OSA severity (Table 1).
When only including the patients who received treatment with medication for the particu-
lar comorbidity, diabetes and hypertension showed a significant increase in prevalence with
greater OSA severity (Table 2). Angina pectoris with treatment showed a similar increase, but
this was not of significance. COPD and asthma with treatment were not associated with OSA
(Table 2).
Table 3 presents the results from the logistic regression analyses with OSA severity (AHI
15) as the dependent variable. Male sex, age, alcohol consumption, heart attack, angina pec-
toris, hypertension, systolic blood pressure140 mmHg, diastolic blood pressure90 mmHg,
diabetes mellitus and obesity were all positively associated with OSA severity. Smoking was
however negatively associated with OSA severity in the crude analyses. Asthma showed a non-
significant negative association with OSA severity. In the multivariate (adjusted) regression
analyses hypertension, systolic blood pressure140 mmHg, diastolic blood pressure90
mmHg, diabetes mellitus and obesity remained positively associated when adjusted for age
and sex. Similarly, when adjusted for age, sex, alcohol and smoking, hypertension, systolic
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blood pressure140 mmHg, diastolic blood pressure90 mmHg and obesity remained posi-
tively associated with OSA severity. Furthermore, when BMI was included as co-variate
together with age, sex, alcohol and smoking, diastolic blood pressure remained positively asso-
ciated with OSA severity (OR = 1.55, CI = 1.19–2.02), and in addition, COPD became nega-
tively associated with OSA severity (OR = 0.54, CI = 0.30–0.97).
Linear regressions with AHI as dependent variable showed a positive association with heart
attack (B = 7.45, std.error = 1.87, beta = 0.093, t = 3.98, p<0.0005), angina pectoris (B = 5.71,
std.error = 2.11, beta = 0.064, t = 2.71, p = 0.007), hypertension (B = 7.52, std.error = 0.86,
beta = 0.20, t = 8.80, p<0.0005), measured systolic blood pressure140 mmHg (B = 5.87, std.
error = 0.92, beta = 0.16, t = 6.41, p<0.0005), measured diastolic blood pressure90 mmHg
(B = 7.39, std.error = 1.01, beta = 0.18, t = 7.31, p<0.0005), diabetes mellitus (B = 5.23, std.
error = 1.43, beta = 0.085, t = 3.65, p<0.0005), and obesity (B = 8.52, std.error = 0.83,
beta = 0.24, t = 10.27, p<0.0005). Linear regressions with AHI as dependent variable showed
no association with stroke (B = 1.00, std.error = 2.58, beta = 0.009, t = 0.39, p = 0.70), COPD
(B = -0.037, std.error = 2.23, beta = 0.00, t = -0.017, p = 0.99) and asthma (B = -1.95, std.
error = 1.10, beta = -0.042, t = -1.77, p = 0.077).
Table 1. Characteristics of patients (n = 1887) referred to a university hospital with suspicion of obstructive sleep apnea.
No OSA Mild OSA Moderate OSA Severe OSA Chi-square
p-value
Patients, % (n) 37.9 (716) 29.6 (558) 17.3 (327) 15.2 (286)
Sex, males, % (n) 63.3 (453) 67.7 (378) 79.5 (260) 84.3 (241) <.0005
Smoking, % (n) 27.8 (187) 24.5 (129) 21.3 (66) 19.7 (52) 0.03
Alcohol3d/week % (n) 5.9 (41) 6.4 (35) 10.0 (32) 10.0 (28) 0.03
Heart attack, % (n) 2.6 (18) 5.0 (27) 7.3 (23) 9.0 (25) <.0005
Angina pectoris, % (n) 2.8 (19) 3.2 (17) 6.3 (19) 6.6 (18) .009
Stroke, % (n) 2.3 (16) 2.3 (12) 3.6 (11) 3.4 (9) .56
Hypertension, % (n) 22.8 (156) 35.2 (189) 41.3 (131) 53.3 (147) <.0005
SBP 140 mmHg, % (n) 22.7 (139) 33.7 (169) 38.7 (113) 41.4 (110) <.0005
DBP 90 mmHg, % (n) 14.2 (87) 24.0 (120) 29.1 (85) 35.1 (93) <.0005
Diabetes mellitus, % (n) 7.4 (51) 7.1 (38) 12.2 (39) 13.8 (38) .001
COPD, % (n) 3.2 (22) 3.6 (19) 4.8 (15) 3.3 (9) .66
Asthma, % (n) 19.2 (131) 17.4 (93) 13.4 (42) 16.1 (44) .15
Obesity, BMI30, % (n) 30.1 (197) 44.6 (232) 41.0 (126) 64.7 (180) <.0005
SBP: Measured systolic blood pressure, DBP: Measured diastolic blood pressure,
COPD: chronic obstructive pulmonary disease, BMI: body mass index.
https://doi.org/10.1371/journal.pone.0192671.t001
Table 2. Angina pectoris, hypertension, diabetes mellitus, COPD and asthma treated with medication among patients (n = 1887) referred to a university hospital
with suspicion of obstructive sleep apnea.
No OSA Mild OSA Moderate OSA Severe OSA Chi-square
p-value
Angina pectoris, treated with medication, % (n) 1.8 (12) 2.8 (15) 4.0 (12) 4.8 (13) .06
Hypertension, treated with medication, % (n) 16.7 (112) 24.0 (126) 33.3 (105) 44.5 (121) <.0005
Diabetes mellitus, treated with medication, % (n) 5.2 (36) 4.7 (25) 9.7 (31) 10.9 (30) <.0005
COPD, treated with medication, % (n) 2.3 (16) 2.6 (14) 3.8 (12) 2.9 (8) .61
Asthma, treated with medication, % (n) 11.4 (76) 11.0 (57) 9.6 (30) 10.0 (27) .82
COPD: chronic obstructive pulmonary disease.
https://doi.org/10.1371/journal.pone.0192671.t002
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Table 3. Logistic regression analyses with moderate to severe obstructive sleep apnea (OSA with AHI15) as the dependent variable among patients (n = 1887)
referred to a university hospital with suspicion of obstructive sleep apnea.
Moderate-severe OSA
Characteristics
(n in crude analysis)
Crude OR (95% CI) Adjusted OR (95% CI)a
n = 1669–1839




Male (1332) 2.39 (1.89–3.02)
Age (1887) 1.05 (1.04–1.06)
Alcohol
No (1703) 1.00 1.00
Yes (136) 1.70 (1.19–2.42) 1.19 (0.82–1.73)
Smoking
No (1339) 1.00 1.00
Yes (434) 0.72 (0.57–0.92) 0.89 (0.69–1.15)
Heart attack
No (1723) 1.00 1.00 1.00
Yes (93) 2.30 (1.51–3.50) 1.08 (0.69–1.69) 1.02 (0.64–1.63)
Angina pectoris
No (1696) 1.00 1.00 1.00
Yes (73) 2.21 (1.38–3.53) 1.33 (0.81–2.19) 1.34 (0.79–2.27)
Stroke
No (1741) 1.00 1.00 1.00
Yes (48) 1.53 (0.85–2.73) 0.83 (0.45–1.54) 0.82 (0.44–1.54)
Hypertension
No (1192) 1.00 1.00 1.00
Yes (623) 2.24 (1.83–2.75) 1.54 (1.23–1.93) 1.57 (1.24–1.98)
SBP 140
No (1139) 1.00 1.00 1.00
Yes (531) 1.74 (1.40–2.15) 1.30 (1.03–1.64) 1.28 (1.01–1.63)
DBP 90
No (1284) 1.00 1.00 1.00
Yes (385) 2.05 (1.63–2.59) 1.83 (1.43–2.35) 1.81 (1.40–2.34)
Diabetes mellitus
No (1654) 1.00 1.00 1.00
Yes (166) 1.90 (1.38–2.63) 1.45 (1.02–2.06) 1.39 (0.97–1.98)
COPD
No (1736) 1.00 1.00 1.00
Yes (65) 1.22 (0.73–2.04) 0.68 (0.39–1.18) 0.67 (0.38–1.18)
Asthma
No (1492) 1.00 1.00 1.00
Yes (310) 0.76 (0.58–1.00) 0.87 (0.65–1.16) 0.91 (0.68–1.22)
Obesity, BMI30
No (1024) 1.00 1.00 1.00
Yes (735) 1.91 (1.56–2.33) 2.24 (1.80–2.79) 2.29 (1.83–2.87)
a: Adjusted for age and sex,
b: Adjusted for age, sex, smoking and alcohol, BMI: body mass index, SBP: Measured systolic blood pressure, DBP: Measured diastolic blood pressure, COPD: chronic
obstructive pulmonary disease.
https://doi.org/10.1371/journal.pone.0192671.t003
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The results from logistic regression analyses using the comorbidity parameters as depen-
dent variables and OSA severity (mild, moderate, severe) as co-variate are shown in Table 4.
Increasing OSA severity was associated with higher prevalence of heart attack, angina pectoris,
hypertension, diabetes mellitus and obesity with mild OSA being the reference.
Discussion
Among patients referred on suspicion of OSA there was a higher prevalence of heart attack,
angina pectoris, hypertension, diabetes mellitus, and obesity with greater OSA severity. This
was also the case for measured systolic blood pressure140 mmHg and diastolic blood pres-
sure90 mmHg. However, there was no significant association between OSA severity and
stroke, COPD and asthma.
Hypertension, measured systolic blood pressure140 mmHg and measured diastolic
blood pressure90 mmHg proved to be significantly associated with OSA severity also after
adjusting for age, sex, smoking and alcohol. These findings support other studies [9–11],
though not all include adjustment for smoking and alcohol [13]. Hypertension, measured sys-
tolic blood pressure140 mmHg and measured diastolic blood pressure90 mmHg were
also statistically significant unique contributors to AHI in the linear regression analyses. This
suggests that hypertension is clearly associated with OSA severity.
Obesity has an indisputable association with OSA [11, 14], also seen in our results. The rela-
tionship between AHI and hypertension has also been suggested to be a result of obesity [13].
However, in our study diastolic blood pressure remained significantly associated with OSA
severity also when BMI was included as co-variate.
As seen in Table 4 and the linear regressions there was a significant association between
OSA severity and heart attack and angina pectoris. However, the two conditions were not asso-
ciated with OSA severity after adjustment with age and sex. This is in contrast to results from
the Sleep Heart Health Study where a significant association of AHI with incident coronary
heart disease was seen in men, however, not in women when adjusting for age [24]. Interest-
ingly, a recent study found no relationship between OSA severity and diagnosed cardiometa-
bolic disease [25].
Fredheim et al. reported that extremely obese patients with type 2 diabetes and prediabetes
have higher odds of OSA, even after adjustment for amongst others age, sex, smoking and
alcohol consumption [26]. This is somehow in contrast to our findings showing that diabetes
mellitus did not remain significantly associated with OSA after adjusting for age, sex, smoking
Table 4. Logistic regression analyses with heart attack, angina pectoris, stroke, hypertension, diabetes mellitus, COPD, asthma, and obesity as the dependent vari-
ables and OSA severity as co-variate among patients (n = 1887) referred to a university hospital with suspicion of obstructive sleep apnea.
Heart attack Angina pectoris Stroke Hypertension Diabetes
mellitus



















Mild (n = 520–
537)
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Moderate
(n = 305–319)
1.48 1.99 1.60 1.30 1.82 1.36 0.73 0.86
(0.83–2.63) (1.02–3.89) (0.70–3.67) (0.98–1.73) (1.14–2.92) (0.68–2.71) (0.49–1.09) (0.65–1.15)
Severe (n = 268–
278)
1.86 2.12 1.50 2.10 2.10 0.92 0.91 2.28
(1.06–3.28) (1.07–4.18) (0.62–3.60) (1.56–2.82) (1.30–3.37) (0.41–2.07) (0.61–1.35) (1.69–3.08)
COPD: chronic obstructive pulmonary disease, BMI: body mass index.
https://doi.org/10.1371/journal.pone.0192671.t004
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and alcohol. However, Fredheim et al. used glucose tolerance tests to identify cases, and also in
our study we found a clear association between diabetes and AHI in the linear regression anal-
yses with increasing prevalence with greater OSA severity.
COPD and asthma were not associated with OSA severity in our study. This is in contrast
to Greenberg-Dotan et al.’s findings [17]. Steveling et al. have previously reported that BMI
and smoking (pack years) were the only predictors for OSA in a group of COPD patients [27].
COPD patients often experience a reduction in BMI with increasing severity of COPD (GOLD
stages). Our study also reports that obesity (BMI30) has a significant association with OSA
severity. When BMI was included as a co-variate in our logistic regression analyses COPD was
negatively associated with OSA severity. It could be of interest in future studies to examine the
prevalence of OSA in the different GOLD stages, preferably with a study design avoiding as
much selection bias as possible. Subjects with obstructive lung diseases frequently experience
sleep disordered breathing [28], which might be perceived as asthma or COPD symptoms
only, thus keeping them away from adequate OSA diagnostics.
In our study stroke was not associated with OSA severity. This is in contrast to Redline
et al.’s findings that increasing OSA severity was significantly associated with increased stroke
risk, even after adjustment for amongst others BMI, smoking, systolic blood pressure and dia-
betes [16]. Their study was a longitudinal cohort study, using polysomnography instead of a
type 3 portable monitor.
Diabetes and hypertension showed a significant increase in prevalence with greater OSA
severity among the patients receiving medication for the particular comorbidity. These results
correlated with the results from the total patient group. This is of interest as treatment for the
particular comorbidity can indicate severity of the comorbidity. On the other hand, medica-
tion will benefit the patient and a well-medicated disease may provide a healthier individual
than without medication. Regarding this, OSA has been reported particularly prevalent in
drug-resistant hypertension [29]. Our results with patients receiving medications should how-
ever be interpreted with caution, as it is difficult to draw conclusions as to what they indicate.
As seen in other studies, being male was positively associated with OSA severity [2, 4]. Sur-
prisingly, there was a negative association between smoking and OSA severity. A possible
explanation could be that smoking has become a well-known health hazard, possibly giving
the patient increased incentive to quit smoking and easier for doctors to address to their
patients. Smoking is considered a possible, but not established risk factor for OSA [2]. In con-
trast to our results Wetter et al. discovered a dose-response relationship between smoking and
severity of sleep apnea [30].
A variety of associations between OSA and alcohol consumption have been reported [2,
31], and in our study alcohol was positively associated with OSA severity. Whereas smoking
has become easier to address to patients over the years, alcohol consumption is perhaps less
easy to address.
In our study, we chose to treat obesity as a disorder. Due to this BMI was not included as a
risk factor, nor adjusted for in the analyses. Several of the comorbidities in interest are
included in the metabolic syndrome, a cluster of risk factors for cardiovascular disease. While
having slightly different definitions [32], metabolic syndrome covers amongst others abdomi-
nal obesity, hypertension and hyperglycemia [33]. OSA can be perceived in association with
metabolic syndrome. Adjusting for only one of the components of the metabolic syndrome
would be artificial, while adjusting for all components would most likely leave no significant
associations.
There are various strengths and limitations to the present study. An important advantage
was the study’s large sample size, giving weight to the results. Another strength was that a
nurse and a doctor revised the questionnaire filled out by the patient during the consultation,
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and made changes if necessary. This functioned as a quality control of the answers filled out, in
the case the patient had misunderstood the question. Measuring blood pressure and calculat-
ing BMI from height and weight provided objective information, hence strengthening the
study. Another asset was that we studied the association between OSA severity and several
somatic comorbidities treated with medication. Furthermore, both logistic and linear regres-
sions were conducted, adding weight to the findings. One of the limitations to our study was
that the somatic diagnoses were based on self-report. This gives room for human error such as
the patient delivering misunderstood, subjective or false answers, not detected by the nurse or
doctor revising the answers. Another limitation was that the diagnoses proclaimed by the
patient were not controlled or set by the means of blood samples, lung function tests or a com-
plete clinical examination. It can also be mentioned that our study did not differentiate
between diabetes mellitus type 1 and type 2. The difference in pathogenesis between the two
types of diabetes mellitus could indicate different associations with OSA severity. The dichot-
omy for alcohol consumption also serves as a limitation. Alcohol consumption has a cultural
aspect, complicating the classification of “normal” and “excessive” alcohol consumption. This
study was based on patients referred to a University hospital on suspicion of OSA. Hence,
selection bias may have been introduced compared to the distribution of co-morbid diseases
to OSA in the community. However, close to all patients in this region of Norway need to be
referred to this hospital for CPAP treatment. It is therefore likely that the results are generaliz-
able to other patients referred to hospital settings with suspicion of OSA, as mentioned previ-
ously by Bjorvatn et al. [23]. Our study design may have resulted in an under-selection of
subjects suffering from conditions with overlapping symptoms with OSA, such as asthma and
COPD. In addition, it is important to note that the “No OSA”-group was not equivalent to a
healthy, general population. As mentioned previously in another study [23], a limitation was
related to using polygraphy, and not polysomnography, for diagnosing OSA. AHI is underesti-
mated in polygraphic registrations compared to polysomnography [34, 35]. However, we
assume that the association between OSA severity and these somatic disorders would be simi-
lar with polysomnography, but such studies should be performed.
In conclusion, our results emphasize that there is a higher prevalence of heart attack, angina
pectoris, hypertension, diabetes mellitus, and obesity with greater OSA severity. However,
there was no association between OSA severity and stroke, COPD and asthma in our patient
group. Obesity and hypertension, as well as measured systolic blood pressure140 mmHg
and diastolic blood pressure90 mmHg, seemed to be central comorbidities with greater
OSA severity. These conditions are easy to assess in every level of the health system and should
be considered when faced with patients presenting symptoms of OSA.
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